Stockscreener 앱 받기
80.46
0.35%
0.28
시간 외 거래:
80.46
전일 마감가:
$80.18
열려 있는:
$80.25
하루 거래량:
502.36K
Relative Volume:
0.47
시가총액:
$13.96B
수익:
$8.31B
순이익/손실:
$379.00M
주가수익비율:
37.25
EPS:
2.16
순현금흐름:
$385.00M
1주 성능:
-1.38%
1개월 성능:
-5.64%
6개월 성능:
+7.81%
1년 성능:
+20.20%
1일 변동 폭
$79.86
$80.56
1주일 범위
$79.86
$81.59
52주 변동 폭
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
80.46 | 13.91B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
577.81 | 204.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.33 | 55.88B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.38 | 39.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.76 | 35.68B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.13 | 34.85B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-10-01 | 개시 | UBS | Neutral |
| 2025-09-11 | 개시 | Jefferies | Hold |
| 2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | 업그레이드 | Argus | Hold → Buy |
| 2025-06-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-07 | 개시 | Piper Sandler | Neutral |
| 2024-09-26 | 개시 | Wolfe Research | Peer Perform |
| 2024-09-05 | 개시 | BTIG Research | Neutral |
| 2024-06-24 | 개시 | Argus | Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2024-05-10 | 개시 | BofA Securities | Neutral |
| 2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 개시 | Wells Fargo | Equal Weight |
| 2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
Is Solventum stock outperforming the Nasdaq? - MSN
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Finviz
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum earns diamond level supply chain certification for healthcare By Investing.com - Investing.com Australia
Solventum earns diamond level supply chain certification for healthcare - Investing.com
3M at a Crossroads: Strategic Moves and Persistent Headwinds - AD HOC NEWS
Solventum Corporation Reflects on Transformative Year - TipRanks
Wells Fargo Adjusts Price Target on Solventum to $86 From $72, Maintains Equalweight Rating - marketscreener.com
Solventum Corp Reflects on Year of Growth and Transformation - TradingView — Track All Markets
Is Solventum Stock Outperforming the Nasdaq? - Yahoo Finance
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
683 Capital Management LLC Has $493,000 Stake in Solventum Corporation $SOLV - MarketBeat
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat
Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not - Seeking Alpha
Amundi Has $19.79 Million Position in Solventum Corporation $SOLV - MarketBeat
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Should You Add Solventum Corp (SOLV) to Your Portfolio? - Insider Monkey
iSAM Funds UK Ltd Increases Stock Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum (SOLV): Reassessing Valuation After a Strong Year-to-Date Rally and Recent Pullback - Yahoo Finance
Solventum Corporation (SOLV): A Bull Case Theory - Insider Monkey
Solventum Corporation (SOLV): A bull case theory - MSN
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.85%
자본화:
|
볼륨(24시간):